PREVALENCE AND DURATION OF UNDETECTED BREAST CANCER

No abstract is available for this paper.

• Publication year

  1975

• Venue

  The Lancet

• Publication date

  1975-12-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0140-6736(75)91026-0
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of gestational age on screening for neural-tube defects by maternal plasma-A.F.P. measurement.

  1975cited by this paper
• Stratospheric sink for chlorofluoromethanes: chlorine atomc-atalysed destruction of ozone

  1974cited by this paper

• Clinical Impact of Weight-Loss Pharmacotherapy in Patients with Atherosclerotic Cardiovascular Disease

  2020cites this paper
• Immunomodulators: Friends or Enemies in Surgery for Crohn's Disease?

  2019cites this paper
• The protective effect of polyunsaturated fatty acid intake during pregnancy against embryotoxicity of sodium valproate in mice.

  2018cites this paper
• Determination of Dopamine-β-hydroxylase Activity in Human Serum Using UHPLC-PDA Detection

  2018cites this paper
• Role of impulsivity and reward in the anti-obesity actions of 5-HT2C receptor agonists

  2017cites this paper
• Crohn’s Disease: Evolution, Epigenetics, and the Emerging Role of Microbiome-Targeted Therapies

  2016cites this paper
• The Heterogeneity of Obesity: Fitting Treatments To Individuals - Republished Article.

  2016cites this paper
• Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.

  2016cites this paper
• Particular Antiepileptic Drugs and Foetal Malformations

  2016cites this paper
• The Emerging Role of Intraoperative Radiation Therapy [IORT] in Breast Cancer

  2015cites this paper
• Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease.

  2015cites this paper
• 5‐Hydroxytryptamine Medications for the Treatment of Obesity

  2015cites this paper
• Conventional drug therapy for inflammatory bowel disease

  2015cites this paper
• Neural tube defects.

  2014cites this paper
• Combination of very low energy diets and pharmacotherapy in the treatment of obesity: meta‐analysis of published data

  2014cites this paper
• Pharmacotherapy for weight loss: the cardiovascular effects of the old and new agents

  2014cites this paper
• Surveillance des grossesses exposées aux médicaments en France : les registres de malformations congénitales

  2014cites this paper
• Detection of signals of abuse and dependence applying disproportionality analysis

  2014cites this paper
• A review of late-stage CNS drug candidates for the treatment of obesity

  2013cites this paper
• The 5-HT2C Receptor Agonist Lorcaserin Reduces Nicotine Self-Administration, Discrimination, and Reinstatement: Relationship to Feeding Behavior and Impulse Control

  2012cites this paper
• Conventional Medical Management of Crohn’s Disease: Azathioprine and 6-Mercaptopurine

  2012cites this paper
• What is the prognosis for new centrally-acting anti-obesity drugs?

  2012cites this paper
• Phosphodiesterase inhibitors: history of pharmacology.

  2011cites this paper
• Influencing clinical practice regarding the use of antiepileptic medications during pregnancy: Modeling the potential impact on the prevalences of spina bifida and cleft palate in the United States

  2011cites this paper
• Pharmacotherapies for Obesity: Past, Current, and Future Therapies

  2010cites this paper
• Exposure of mice to concentrated ambient particulate matter results in platelet and systemic cytokine activation

  2010cites this paper
• Sleep and rhythm consequences of a genetically induced loss of serotonin.

  2010cites this paper
• Rationale for preoperative screening of anti-HCV antibody

  2010cites this paper
• 5-HT2C receptor modulators: a patent survey

  2010cites this paper
• mRNA expression is a relevant tool to identify developmental neurotoxicants using an in vitro approach.

  2010cites this paper
• Managing Highly Insulin-Resistant Diabetes Mellitus: Weight Loss Approaches and Medical Management

  2010cites this paper
• Subtyping obesity with microarrays: implications for the diagnosis and treatment of obesity

  2009cites this paper
• Ethylbutyrate, a valproate-like compound, exhibits inositol-depleting effects--a potential mood-stabilizing drug.

  2009cites this paper
• Attrition from randomized controlled trials of pharmacological weight loss agents: a systematic review and analysis

  2009cites this paper
• Alcohol and disease: central nervous system.

  2009cites this paper
• Antagonism of glutamatergic NMDA and mGluR5 receptors decreases consumption of food in baboon model of binge-eating disorder.

  2008cites this paper
• The development of tolerance to drugs that suppress food intake.

  2008cites this paper
• Selective 5-HT6 receptor ligands: progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disorders.

  2008cites this paper
• Comparison of combinations of drugs for treatment of obesity: body weight and echocardiographic status

  2007cites this paper
• The role of platelets in the pathophysiology of asthma

  2007cites this paper
• Home versus in-patient treatment for deep vein thrombosis.

  2007cites this paper
• Pharmacological and surgical treatments for obesity.

  2006cites this paper
• The Emergence of 5-HT2B Receptors as Targets to Avoid in Designing and Refining Pharmaceuticals

  2006cites this paper
• Valproic Acid Increases Conservative Homologous Recombination Frequency and Reactive Oxygen Species Formation: A Potential Mechanism for Valproic Acid-Induced Neural Tube Defects

  2006cites this paper
• The ethics of excluding women who become pregnant while participating in clinical trials of anti-epileptic medications.

  2006cites this paper
• Overview and the Future of Obesity Treatment

  2005cites this paper
• Drug Insight: appetite suppressants

  2005cites this paper
• Primary Care in A&E

  2005cites this paper
• Dietary risk factors for the development of inflammatory polyarthritis: evidence for a role of high level of red meat consumption.

  2004cites this paper
• Obesity is a chronic, relapsing neurochemical disease

  2004cites this paper
• Detection of Purkinje cell loss following drug exposures to developing rat pups using reverse transcriptase-polymerase chain reaction (RT-PCR) analysis for calbindin-D28k mRNA expression.

  2004cites this paper
• Combined dietary and pharmacological weight management in obese hypopituitary patients.

  2004cites this paper
• A 6-month randomized, placebo-controlled, dose-ranging trial of topiramate for weight loss in obesity.

  2003cites this paper
• Optimizing the therapeutic potential of azathioprine/6-mercaptopurine in the treatment of inflammatory bowel disease.

  2003cites this paper
• Treatment of obesity: an update on anti‐obesity medications

  2003cites this paper
• Behavioral treatment of obesity.

  2003cites this paper
• Tratamento Farmacológico da Obesidade

  2002cites this paper
• Metabolic imprinting and the obesity epidemic

  2002cites this paper
• c-myc proto-oncogene expression in hemophilic synovitis: in vitro studies of the effects of iron and ceramide.

  2002cites this paper
• Bupropion SR enhances weight loss: a 48-week double-blind, placebo- controlled trial.

  2002cites this paper
• Plasma immunoadsorption therapy for Guillain-Barré syndrome: critical day for initiation.

  2002cites this paper
• Operation for anorexigen-associated valvular heart disease.

  2001cites this paper
• Valproic acid embryopathy: report of two siblings with further expansion of the phenotypic abnormalities and a review of the literature.

  2001cites this paper
• Lifestyle treatments in randomized clinical trials of pharmacotherapies for obesity.

  2001cites this paper
• American College of Preventive Medicine Practice Policy statement. Weight management counseling of overweight adults.

  2001cites this paper
• Antioxidant potential of two polyherbal. preparations used in Ayurveda for the treatment of rheumatoid arthritis.

  2001cites this paper
• Use of Methylene Blue to Treat Methemoglobinemia in Infancy

  2001cites this paper
• Current status of medical and surgical therapy for obesity.

  2001cites this paper
• Focus on primary care: evaluation, management, and treatment of obesity in women.

  2001cites this paper
• Action of valproic acid on Xenopus laevis development: teratogenic effects on eyes.

  2001cites this paper
• Iron and inflammatory bowel disease

  2001cites this paper
• The teratogenic risk of trimethoprim-sulfonamides: a population based case-control study.

  2001cites this paper
• The obesity epidemic: metabolic imprinting on genetically susceptible neural circuits.

  2000cites this paper
• Prenatal exposure to valproic acid during pregnancy and limb deficiencies: a case-control study.

  2000cites this paper
• Brain Death—the Patient, the Physician, and Society

  2000cites this paper
• One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor

  2000cites this paper
• Nutritional Modulation of Autoimmune Diseases

  2000cites this paper
• Ocular microtremor in brain stem death

  1999cites this paper
• Local and systemic responses to iron-dextran injected into a granuloma pouch in the rat.

  1999cites this paper
• Congenital malformations due to antiepileptic drugs.

  1999cites this paper
• Antiepileptic drug regimens and major congenital abnormalities in the offspring

  1999cites this paper
• Ethics and clinical trials 1

  1999cites this paper
• Prevention of Type 2 Diabetes Mellitus

  1999cites this paper
• Blood-induced joint damage: a human in vitro study.

  1999cites this paper
• Teratogen update: methylene blue.

  1999cites this paper
• Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting: a 1-y study.

  1999cites this paper
• A model for chronic care of obesity through dietary treatment.

  1998cites this paper
• Clinical implications of appetite suppressants

  1998cites this paper
• A close look at fenfluramine and dexfenfluramine.

  1998cites this paper
• Quantitation of dexfenflurainine/d‐norfenfluramine concentration in primate brain using 19F NMR spectroscopy

  1998cites this paper
• The surgical treatment of morbid obesity.

  1998cites this paper
• Metformin decreases food consumption and induces weight loss in subjects with obesity with type II non-insulin-dependent diabetes.

  1998cites this paper
• The Maintenance of Treatment Effects in the Long‐Term Management of Obesity

  1998cites this paper
• Central nervous system stimulants and drugs that suppress appetite

  1998cites this paper
• Strategies for preventing type II diabetes. What can be done to stem the epidemic?

  1997cites this paper
• The Solution Method: 2-year trends in weight, blood pressure, exercise, depression, and functioning of adults trained in development skills.

  1997cites this paper
• The Pharmacologic Approach to the Treatment of Obesity

  1997cites this paper
• Long-term pharmacologic treatment of morbid obesity in a community practice.

  1997cites this paper
• Antioxidative and metal-chelating effects of polyamines.

  1997cites this paper
• Teratogenic effects of vigabatrinin TO mouse fetuses

  1997cites this paper